- Latest available (Revised)
- Point in Time (17/12/2020)
- Original (As adopted by EU)
Commission Implementing Decision (EU) 2020/2167 of 17 December 2020 amending Implementing Decision (EU) 2016/1918 concerning certain safeguard measures in relation to chronic wasting disease by extending its period of application (notified under document C(2020) 8802) (Text with EEA relevance)
After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.
The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.
Point in time view as at 17/12/2020.
There are currently no known outstanding effects for the Commission Implementing Decision (EU) 2020/2167.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies(1), and in particular Article 4(2) thereof,
Whereas:
(1) Regulation (EC) No 999/2001 lays down rules for the prevention, control and eradication of transmissible spongiform encephalopathies (TSEs) in the Union. It applies to the production and placing on the market of live animals and products of animal origin and in certain specific cases to exports thereof. It also provides, inter alia, for the adoption of safeguard measures in the event of outbreaks of TSEs.
(2) Commission Implementing Decision (EU) 2016/1918(2) lays down temporary safeguard measures in relation to chronic wasting disease (CWD). It was adopted following the detection of six cases of CWD in cervids in Norway in 2016: four in reindeers and two in moose. That was the first time that CWD had been detected in Europe and the first natural cases in reindeer in the world.
(3) Between January 2017 and September 2020, Norway informed the Commission and the Member States of sixteen additional cases of CWD in wild reindeers, five additional cases of CWD in wild moose, and one case of CWD in a red deer. In 2018, Finland detected the first case of CWD in the Union and an additional one in November 2020. Sweden detected three cases in 2019 and an additional one in September 2020. All cases of CWD detected in Finland and Sweden were found in wild moose.
(4) Point A of Part III of Chapter A of Annex III to Regulation (EC) No 999/2001 provides for a three-year monitoring programme for CWD, covering a period from 1 January 2018 to 31 December 2020. However, the collection of data will partly continue throughout 2021 in accordance with the technical specifications of the monitoring programme, with a view to, eventually, gathering a larger dataset. As a result, the scientific assessment of the results of the monitoring programme, which will be necessary to develop future policy options on CWD, is not expected to be available until 2022.
(5) On 11 November 2019, the European Food Safety Authority published a Scientific Opinion on Update on Chronic Wasting Disease (CWD) III(3) (EFSA Opinion). However, more time is necessary to consider how the conclusions and recommendations set out in the EFSA Opinion should be reflected in Union rules.
(6) Taking into account the detection of new cases of CWD in Norway, Finland and Sweden, and pending the outcome of the three-year monitoring programme for CWD, and pending the scientific assessment of the results of the monitoring programme which is expected in 2022, and considering that additional time is needed to reflect on the EFSA Opinion, the period of application of Implementing Decision (EU) 2016/1918 should be extended until 31 December 2022.
(7) Implementing Decision (EU) 2016/1918 should therefore be amended accordingly.
(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
HAS ADOPTED THIS DECISION:
In Article 4 of Implementing Decision (EU) 2016/1918, the date ‘31 December 2020’ is replaced by the date ‘31 December 2022’.
This Decision is addressed to the Member States.
Done at Brussels, 17 December 2020.
For the Commission
Stella Kyriakides
Member of the Commission
Commission Implementing Decision (EU) 2016/1918 of 28 October 2016 concerning certain safeguard measures in relation to chronic wasting disease (OJ L 296, 1.11.2016, p. 21).
https://doi.org/10.2903/j.efsa.2019.5863
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: